An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 205103
Company: GENUS LIFESCIENCES

Medication Guide

Products on NDA 205103

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
YOSPRALA	ASPIRIN; OMEPRAZOLE	81MG;40MG	TABLET, DELAYED RELEASE;ORAL	Discontinued	None	Yes	No
YOSPRALA	ASPIRIN; OMEPRAZOLE	325MG;40MG	TABLET, DELAYED RELEASE;ORAL	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 205103

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/14/2016	ORIG-1	Approval	Type 4 - New Combination	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205103s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/205103Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/205103Orig1s000TOC.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/21/2024	SUPPL-10	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/205103Orig1s010ltr.pdf
07/18/2023	SUPPL-9	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205103s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/205103Orig1s009ltr.pdf
03/04/2022	SUPPL-8	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205103s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/205103Orig1s008ltr.pdf
04/28/2021	SUPPL-7	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205103Orig1s007ltr.pdf
11/27/2020	SUPPL-6	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/205103Orig1s006ltr.pdf
06/07/2018	SUPPL-4	Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/205103Orig1s004ltr.pdf
10/04/2017	SUPPL-1	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205103Origs001ltr.pdf

Labels for NDA 205103

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/21/2024	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf
07/18/2023	SUPPL-9	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205103s009lbl.pdf
03/04/2022	SUPPL-8	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205103s008lbl.pdf
04/28/2021	SUPPL-7	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf
04/28/2021	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf
11/27/2020	SUPPL-6	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf
11/27/2020	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf
06/07/2018	SUPPL-4	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf
06/07/2018	SUPPL-4	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf
10/04/2017	SUPPL-1	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf
10/04/2017	SUPPL-1	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf
09/14/2016	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205103s000lbl.pdf

Top